DXB

Dimerix Limited

1 day chart

About DXB

Dimerix Limited (DXB) is a clinical-stage biopharmaceutical company developing innovative new therapies in areas with unmet medical needs for global markets. Dimerix is developing its proprietary product DMX-200, for Focal Segmental Glomerulosclerosis (FSGS), respiratory complications associated with COVID-19 and Diabetic Kidney Disease and is developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Receptor-HIT is licensed non-exclusively to Excellerate Bioscience, a UK-based pharmacological assay service provider with a worldwide reputation for excellence in the field of molecular and cellular pharmacology.

Buy Australian shares starting with DXB. Invest today with a CHESS-sponsored investing platform!

Sector

Health Care

CEO

Industry

Biotechnology

Website

dimerix.com

Market Capitalisation

$64M

Price-earnings ratio

-3.54

Dividend yield

NaN%

High today

$0.15

Low today

$0.14

Open price

$0.15

52-week high

$0.23

52-week low

$0.05

Announcements

DXB FAQs

Can I buy DXB shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy DXB shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Dimerix Limited?

One share of Dimerix Limited is valued at $0.15.

What is the ticker symbol for Dimerix Limited?

The ticker symbol for Dimerix Limited is DXB.

How do I buy DXB shares in Australia?

To buy DXB stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in DXB

What is the 52-week high for Dimerix Limited stock?

The Dimerix Limited 52-week high stock price is $0.23.

What is the 52-week low for Dimerix Limited stock?

The Dimerix Limited 52-week low stock price is $0.05.

What is the market capitalisation of Dimerix Limited DXB?

As of 05/12/2023 Dimerix Limited has a market cap of $64M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.